Jefferies Financial Group restated their buy rating on shares of Croda International (LON:CRDA – Free Report) in a research report sent to investors on Wednesday, MarketBeat reports. The firm currently has a GBX 3,200 price target on the stock.
Several other analysts have also commented on CRDA. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Croda International from GBX 3,400 to GBX 3,000 and set a “hold” rating for the company in a report on Tuesday, July 29th. JPMorgan Chase & Co. upgraded shares of Croda International to an “overweight” rating in a report on Wednesday, July 30th. Finally, Berenberg Bank lowered their price objective on shares of Croda International from GBX 3,800 to GBX 3,100 and set a “buy” rating for the company in a report on Tuesday, July 29th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of GBX 3,150.
View Our Latest Report on CRDA
Croda International Stock Performance
Croda International (LON:CRDA – Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported GBX 72.20 EPS for the quarter. Croda International had a net margin of 9.98% and a return on equity of 6.96%. On average, analysts anticipate that Croda International will post 181.8307268 EPS for the current fiscal year.
Insider Buying and Selling
In related news, insider Jacqui Ferguson bought 393 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The shares were bought at an average price of GBX 2,524 per share, for a total transaction of £9,919.32. Also, insider Ian Bull bought 500 shares of the company’s stock in a transaction that occurred on Friday, August 1st. The stock was bought at an average price of GBX 2,643 per share, for a total transaction of £13,215. Insiders have bought a total of 11,343 shares of company stock valued at $29,823,659 in the last ninety days. Corporate insiders own 0.83% of the company’s stock.
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Featured Stories
- Five stocks we like better than Croda International
- How to buy stock: A step-by-step guide for beginners
- Datavault AI: The New AI Contender Backed by Big Funding
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- What to Know About Investing in Penny Stocks
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.